M16-111
ClinicalTrials.gov NCT03924947
Research payments
$680,534
Through program year 2020, $680,534 in research payments was reported against M16-111, across 44 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03924947
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $680,534 | 44 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Schaeffer Jacksonville, FL Named on 12 payments
- Daniel Layish Orlando, FL Named on 11 payments
- Virginia Stallings Philadelphia, PA Named on 6 payments
- Michael Schechter Richmond, VA Named on 4 payments
- Richard Ahrens Iowa City, IA Named on 4 payments
- Douglas Lewis Wichita, KS Named on 3 payments
- Adupa Rao Los Angeles, CA Named on 2 payments
- Christopher Landon Ventura, CA Named on 1 payment
- Rebekah Brown Nashville, TN Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.